Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities

Clinical trial NCT06107829 · WITHDRAWN

Trial details

NCT number: NCT06107829
Sponsor: Stephen Ruedrich
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Tardive Dyskinesia Intellectual Disability Developmental Disabilities

Start date: 2025-01-01
Primary completion: 2027-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.